Pierre Van Damme Selected Research

Poliomyelitis (Polio)

7/2021	Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses.
1/2021	Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
1/2020	Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence.
10/2019	Poliopolis: pushing boundaries of scientific innovations for disease eradication.
1/2019	The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.
6/2015	An open-label, randomized study of a 9-valent human papillomavirus vaccine given concomitantly with diphtheria, tetanus, pertussis and poliomyelitis vaccines to healthy adolescents 11-15 years of age.
4/2010	An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
8/2009	Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium.
3/2009	Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.
11/2007	Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus-toxoid vaccines.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Van Damme Research Topics

Disease

31	Whooping Cough (Pertussis) 01/2022 - 03/2003
28	Hepatitis B 01/2022 - 06/2002
24	Tetanus 01/2021 - 03/2003
24	Diphtheria 01/2021 - 03/2003
22	Infections 01/2022 - 06/2004
18	Hepatitis A (Hepatitis, Infectious) 01/2021 - 06/2002
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 12/2008
12	Human Influenza (Influenza) 12/2022 - 03/2003
11	Poliomyelitis (Polio) 07/2021 - 07/2005
9	Communicable Diseases (Infectious Diseases) 01/2022 - 08/2005
8	Measles 12/2022 - 02/2003
7	COVID-19 01/2022 - 12/2020
6	Rubella (German Measles) 01/2021 - 11/2005
6	Mumps 01/2021 - 11/2005
6	Neoplasms (Cancer) 01/2019 - 11/2012
5	Papillomavirus Infections 01/2019 - 11/2012
5	Hepatitis 01/2013 - 03/2003
4	Pain (Aches) 01/2021 - 01/2014
4	Multiple Sclerosis 01/2016 - 11/2005
4	Gastroenteritis 08/2012 - 01/2006
3	Headache (Headaches) 01/2021 - 04/2010
3	Malaria 05/2019 - 01/2004
3	Herpes Zoster 01/2018 - 01/2003
2	Breakthrough Infections 11/2022 - 01/2013
2	Typhoid Fever (Typhoid) 05/2019 - 11/2003
2	Meningitis 01/2019 - 08/2008
2	Warts (Wart) 01/2019 - 01/2016
2	Intussusception 06/2015 - 01/2006
2	Vaccine-Preventable Diseases 08/2014 - 02/2003
2	Hepatitis E 10/2012 - 01/2010
2	Chickenpox 05/2005 - 01/2003
2	Liver Diseases (Liver Disease) 06/2004 - 06/2002
1	Myalgia 01/2021
1	Fatigue 01/2021
1	Pneumococcal Infections 01/2020
1	Rabies (Hydrophobia) 05/2019
1	Japanese Encephalitis 05/2019
1	Yellow Fever 05/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Bacterial Meningitis 01/2019
1	Uterine Cervical Dysplasia 01/2019
1	Common Cold 01/2018
1	Condylomata Acuminata (Genital Wart) 01/2018

Drug/Important Bio-Agent (IBA)

104	VaccinesIBA 12/2022 - 06/2002
26	AntibodiesIBA 01/2022 - 06/2002
17	AntigensIBA 01/2020 - 06/2002
12	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2021 - 07/2002
10	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 01/2007
5	Papillomavirus Vaccines (HPV Vaccines)IBA 08/2021 - 10/2011
5	Pertussis ToxinIBA 01/2021 - 06/2003
5	pertactin FDA Link 01/2017 - 06/2003
5	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 10/2015 - 11/2003
4	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2021 - 10/2008
4	Pertussis VaccineIBA 11/2020 - 01/2016
4	Combined VaccinesIBA 11/2020 - 06/2004
4	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 10/2020 - 11/2007
4	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018 - 01/2009
4	RotaTeqIBA 06/2015 - 12/2009
4	Pentetic Acid (DTPA)FDA LinkGeneric 08/2011 - 03/2003
3	Immunoglobulin G (IgG)IBA 01/2021 - 08/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2015
3	Biological ProductsIBA 01/2016 - 01/2009
3	Rotavirus VaccinesIBA 08/2012 - 03/2009
3	twinrixIBA 03/2011 - 06/2004
2	EpitopesIBA 01/2022 - 01/2019
2	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 01/2021 - 03/2003
2	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 01/2021 - 10/2019
2	Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link 10/2020 - 10/2017
2	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 10/2020 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2017
2	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 06/2003
2	Hepatitis A AntibodiesIBA 01/2017 - 11/2016
2	BoostrixIBA 01/2016 - 01/2004
2	RIX4414 vaccineIBA 06/2015 - 12/2009
2	Thimerosal (Thiomersal)IBA 04/2007 - 11/2005
2	Engerix-BIBA 04/2007 - 06/2006
1	Recombinant ProteinsIBA 12/2022
1	NucleoproteinsIBA 12/2022
1	COVID-19 VaccinesIBA 11/2022
1	Immunoglobulin A (IgA)IBA 01/2021
1	Inactivated VaccinesIBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 01/2021
1	Pharmaceutical PreparationsIBA 12/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Anti-Idiotypic AntibodiesIBA 01/2020
1	BCG Vaccine FDA Link 05/2019
1	Antiviral Agents (Antivirals)IBA 05/2019
1	Interferon Type IIBA 01/2019
1	InterferonsIBA 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	HLA-A Antigens (HLA-A)IBA 01/2018

Therapy/Procedure

2	Personal Protective Equipment 01/2022 - 01/2021
2	Therapeutics 01/2019 - 01/2015
2	Injections 01/2014 - 01/2009
1	Aftercare (After-Treatment) 08/2021
1	Chemoprevention 05/2019
1	Medical Day Care (Partial Hospitalization) 01/2018